Literature DB >> 19772798

The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis.

A Chatzikyriakidou1, I Georgiou, P V Voulgari, A A Drosos.   

Abstract

OBJECTIVE: Ankylosing spondylitis (AS) is a chronic inflammatory disease affecting the sacroiliac joint and vertebral column. Tumor necrosis factor alpha (TNF-alpha), a cytokine that acts via two tumor necrosis factor receptors (TNFR1 and TNFR2), may be implicated in the pathogenesis of AS. The aim of the present study was to examine the role of the polymorphisms 36A>G (TNFR1), 676T>G (TNFR2), -857C>T (TNF-alpha), -308G>A (TNF-alpha), and -238G>A (TNF-alpha) in AS susceptibility.
METHODS: Forty-nine AS patients and 68 randomly chosen healthy volunteers were enrolled in the study. Polymerase chain reaction coupled with a restriction fragment length polymorphism assay was performed in the genotype analysis of each variant.
RESULTS: The polymorphisms 36A>G (TNFR1) and -238G>A (TNF-alpha were not found to be in Hardy-Weinberg equilibrium in the patient group and therefore were excluded from the statistical analysis. A marginally statistically significant difference was observed in the distribution of 676T>G (TNFR2) genotypes between AS patients and controls (p=0.054) and was revealed to be more significant in the 676T>G allele distribution between the two groups (p=0.031). The complex genotype TNFR2 676TG/ TNF-alpha -857CC (p=0.041) was also differently distri-buted between AS patients and controls.
CONCLUSIONS: The TNFR2 676T allele is reported here for first time to be differently distributed between AS patients and controls. The higher frequency of the wild type TNFR2 676T allele in AS patients suggests the functional ability of TNFR2 to support increased TNF-alpha mediated immunoactivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19772798

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  19 in total

1.  The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis.

Authors:  Bing Li; Pei Wang; Hui Li
Journal:  Clin Rheumatol       Date:  2010-06-11       Impact factor: 2.980

Review 2.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

Review 3.  The association of polymorphisms in TNF and ankylosing spondylitis in common population: a meta-analysis.

Authors:  Huae Shu; Hongsheng Sun; Naiwen Hu; Xi Chen; Shanjuan Wang; Gangying Yuan; Qinqin Wang
Journal:  Eur Spine J       Date:  2021-04-20       Impact factor: 3.134

Review 4.  TNF receptor 2 pathway: drug target for autoimmune diseases.

Authors:  Denise Faustman; Miriam Davis
Journal:  Nat Rev Drug Discov       Date:  2010-05-21       Impact factor: 84.694

5.  -383 A/C tumor necrosis factor receptor 1 polymorphism and ankylosing spondylitis in Mexicans: a preliminary study.

Authors:  Esther Guadalupe Corona-Sanchez; José Francisco Muñoz-Valle; Laura Gonzalez-Lopez; Julia Dolores Sanchez-Hernandez; Monica Vazquez-Del Mercado; Heriberto Ontiveros-Mercado; Miguel Huerta; Xochitl Trujillo; Alberto Daniel Rocha-Muñoz; Alfredo Celis; Ricardo Ortega-Flores; Jorge Ivan Gamez-Nava
Journal:  Rheumatol Int       Date:  2011-07-26       Impact factor: 2.631

Review 6.  TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4+ T-Cell Metabolism.

Authors:  Mark Mensink; Thi Ngoc Minh Tran; Esther A Zaal; Ellen Schrama; Celia R Berkers; Jannie Borst; Sander de Kivit
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 7.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

8.  A Short Peptide That Mimics the Binding Domain of TGF-β1 Presents Potent Anti-Inflammatory Activity.

Authors:  Emília R Vaz; Patrícia T Fujimura; Galber R Araujo; Carlos A T da Silva; Rangel L Silva; Thiago M Cunha; Mônica Lopes-Ferreira; Carla Lima; Márcio J Ferreira; Jair P Cunha-Junior; Ernesto A Taketomi; Luiz R Goulart; Carlos Ueira-Vieira
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

Review 9.  A meta-analysis for association of TNF-α -308G>A polymorphism with susceptibility to Ankylosing Spondylitis.

Authors:  Masoud Mahdinejad-Yazdi; Mohammad Reza Sobhan; Seyed Alireza Dastgheib; Reza Bahrami; Seyed Hossein Shaker; Hamid Mirjalili; Jalal Sadeghizadeh-Yazdi; Masoud Zare-Shehneh; Hossein Neamatzadeh
Journal:  J Orthop       Date:  2021-07-14

10.  Ankylosing spondylitis: from cells to genes.

Authors:  José Francisco Zambrano-Zaragoza; Juan Manuel Agraz-Cibrian; Christian González-Reyes; Ma de Jesús Durán-Avelar; Norberto Vibanco-Pérez
Journal:  Int J Inflam       Date:  2013-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.